2m 2m 2m 2m 2m 2m 2m
Exozymes (EXOZ)
NASDAQ
$8.05+$0.34 (+4.48%)
Price as of Jun 23, 2026 6:29 PM EDT- $74.5MMarket Cap
- -22.10%1-Year Change
- BiotechnologyIndustry
Exozymes (EXOZ)
$8.05+$0.34 (+4.48%)
EXOZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $7.70 | ||
Change | -$0.48 (-5.87%) | ||
Open | $8.02 | ||
High | $8.10 | ||
Low | $7.70 | ||
Previous Close | $8.18 | ||
Volume | 3,886 | ||
30-Day Average Volume | 7,437 | ||
1-Week Change | 3.77% | ||
1-Month Change | -22.38% | ||
1-Year Change | -25.39% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 9.1M | ||
Total Assets | $4.0M | ||
Market Cap | $74.5M | ||
Enterprise Value | $73.1M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.6M | ||
EBIT | $0.00 | ||
EBITDA | $74,147.00 | ||
Net Working Capital | $507,585.00 | ||
EPS | -$0.28 | ||
Enterprise Value/EBITDA | 986 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 49 | ||
P/E | -29 | ||
PEG | N/A | ||
Price/Free Cash Flow | -47 | ||
Price/Operating Cash Flow | -49 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue